Dark

Check out our Dark Pool Levels

RTRX
Retrophin, Inc. Common Stock
stock NASDAQ

Inactive

Nov 18, 2020 3:59:00 PM EST

24.24USD+2.365%(+0.56)289,237

Pre-market

0.00USD-100.000%(-23.53)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Nov 30, 2020

04:05PM EST Travere Therapeutics Announces Completion of Patient Enrollment in GlobeNewswire Inc

Nov 16, 2020

08:12AM EST Retrophin Announces Corporate Name Change To Travere Therapeutics, Inc. And Ticker Change To 'TVTX' Effective Nov. 19 Benzinga

08:00AM EST New name reflects dedication to patient-inspired mission of identifying, developing and delivering life-changing rare disease therapies GlobeNewswire Inc

Nov 12, 2020

04:05PM EST Retrophin Completes Acquisition of Orphan Technologies GlobeNewswire Inc

07:44AM EST The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal Benzinga

Nov 11, 2020

04:30PM EST Retrophin, Inc. (NASDAQ: RTRX) today announced that Company management will present at the following upcoming virtual investor conferences in November and December: GlobeNewswire Inc

07:38AM EST The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap Benzinga

Nov 6, 2020

07:31AM EST BMO Capital Maintains Outperform on Retrophin, Raises Price Target to $33 Benzinga

Nov 5, 2020

04:41PM EST Retrophin Q3 EPS $(0.11) Up From $(0.66) YoY, Sales $51.14M Beat $48.14M Estimate Benzinga

07:54AM EST The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping Benzinga

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Nov 1, 2020

09:40AM EST The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings Benzinga

Oct 26, 2020

03:26PM EDT Notable Earnings Watchlist For Tuesday, Oct. 27, 2020 Before Market Open: NVS, BP, SWK, LLY, QSR, XRX, CAT, MRK, PFE, HOG, DTE, RTRX, ODFL, JBLU, GLW, CMI, MMM, BEN Benzinga

Oct 22, 2020

04:05PM EDT Retrophin Announces Agreement To Acquire Orphan Technologies For $90M Upfront Payment, $427M In Additional Cash Payments Contingent On Drug Milestones Benzinga

04:01PM EDT Agreement adds OT-58, a novel enzyme replacement therapy in Phase 1/2 development for the treatment of classical homocystinuria GlobeNewswire Inc

Oct 21, 2020

04:30PM EDT Retrophin, Inc. (NASDAQ: RTRX) today announced it will report third quarter 2020 financial results on Thursday, November 5, 2020 after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET. GlobeNewswire Inc

Oct 14, 2020

05:00PM EDT Retrophin, Inc. Reports Inducement Grants Under Nasdaq Listing GlobeNewswire Inc

Oct 9, 2020

04:02PM EDT Retrophin Announces Presentation of Abstracts at ASN Kidney Week 2020 Reimagined Benzinga

04:01PM EDT Retrophin Announces Presentation of Abstracts at ASN Kidney Week GlobeNewswire Inc

Sep 21, 2020

08:16AM EDT Retrophin Says First 280 Patients Enrolled In Pivotal Phase 3 PROTECT Study On Sparsentan RTTNews

08:03AM EDT Retrophin Announces Enrollment Of First 280 Patients In Pivotal Phase 3 PROTECT Study Of Sparsentan In IgA Nephropathy Benzinga

08:00AM EDT Retrophin Announces Enrollment of First 280 Patients in Pivotal GlobeNewswire Inc

Sep 18, 2020

09:31AM EDT Benzinga's Top Upgrades, Downgrades For September 18, 2020 Benzinga

05:26AM EDT Wedbush Initiates Coverage On Retrophin with Outperform Rating, Announces Price Target of $33 Benzinga

Sep 14, 2020

05:00PM EDT Retrophin, Inc. Reports Inducement Grants Under Nasdaq Listing GlobeNewswire Inc

Aug 24, 2020

09:34AM EDT Benzinga's Top Upgrades, Downgrades For August 24, 2020 Benzinga

07:29AM EDT B of A Securities Initiates Coverage On Retrophin with Buy Rating, Announces Price Target of $30 Benzinga

Aug 3, 2020

04:30PM EDT Retrophin, Inc. (NASDAQ: RTRX) today announced that Company management will participate in the following upcoming virtual investor conferences in August: GlobeNewswire Inc

Jul 30, 2020

04:13PM EDT Retrophin Q2 EPS $(0.22) Beats $(0.55) Estimate, Sales $48.40M Beat $47.08M Estimate Benzinga

04:06AM EDT Earnings Scheduled For July 30, 2020 Benzinga

Jul 16, 2020

04:30PM EDT Retrophin, Inc. (NASDAQ: RTRX) today announced it will report second quarter 2020 financial results on Thursday, July 30, 2020 after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET. GlobeNewswire Inc

Share